Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.53B.
ENTERPRISE VALUE (EV)
$1.53B
Eton Pharmaceuticals, Inc.
Market Cap
$1.52B
Enterprise Value (EV)
$1.53B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Eton Pharmaceuticals, Inc. (ETON) | $1.52B | $1.53B |
| Innoviva, Inc. (INVA)vs › | $1.53B | $1.23B |
| GH Research PLC (GHRS)vs › | $1.51B | $1.16B |
| Certara, Inc. (CERT)vs › | $1.57B | $1.68B |
| Braveheart Bio, Inc. (BRVE)vs › | $1.48B | N/A |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.47B | $1.33B |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.47B | $1.33B |
| AnaptysBio, Inc. (ANAB)vs › | $1.43B | $1.57B |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.40B | $1.27B |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.64B | $1.61B |
Market Cap
$1.52B
Total Debt
$30.56M
Cash
$25.94M
Enterprise Value
$1.53B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
